HealthExecStore

Webinar: Telehealth Readiness – Current Legal, Regulatory and Corporate Practice Considerations

$260.00 USD

Sale Sold out

Quantity

View this On-Demand Webinar session with Epstein Becker Green’s Amy Lerman and Priya Kaulich providing healthcare organizations that are exploring and evaluating offering telehealth services, a thorough examination of the legal, regulatory and corporate structural implications, issues, and challenges, in the HealthcareWebSummit event: Telehealth Readiness: Current Legal, Regulatory and Corporate Practice Considerations.

Overview

Webinar: Thursday, April 16, 2020, at 1:00 PM – 2:00 PM Eastern

Key legal and regulatory telehealth issues
Corporate formation and corporate practice of medicine considerations
Implications of applicable telehealth modalities to deploy
Potential regulatory developments in the current environment

Faculty: Amy Lerman, Member of the Firm, Epstein Becker Green and Priya Kaulich, Associate, Epstein Becker Green

In this current environment, healthcare organizations not already providing telehealth services are faced with critical decisions regarding developing such capabilities for the populations they serve. However, there are myriad legal and regulatory complexities in doing so, particularly at the state level.

During this session, Epstein Becker Green attorneys Amy Lerman and Priya Kaulich lend their noted national telehealth legal and regulatory expertise to healthcare organizations that are in various stages of exploring and evaluating offering telehealth services. Key national and state-level legal, regulatory and corporate structural considerations will be addressed, including:

Corporate Practice Considerations
Professional Licensure
Establishing Practitioner-Patient Relationships
Scope of Practice / Delegation
Remote Prescribing
Coverage and Reimbursement
Privacy and Security
Fraud and Abuse
Enforcement and Professional Liability

Time for audience questions and answers will be provided.

Please join us on Thursday, April 16, 2020, at 1 PM Eastern for this timely and informative HealthcareWebSummit event: Telehealth Readiness: Current Legal, Regulatory and Corporate Practice Considerations.

Video Preview:

Registration Details

Individual Registration: $195
Individual Registration and Post-event materials - Includes webinar video and presentation pdf file: $240 for attendees
Post-event materials for non-attendees - Includes webinar video and presentation pdf file. Available after the event: $260

Register above or download a registration form. You can also register by phone: 209.577.4888. Corporate Site licensing also available. We look forward to your attendance!

MCOL Premium members receive a 50% discount on all Healthcare Web Summit events. Members can get the discount code on the Premium Member Website. Non-members can learn about MCOL Premium memberships and sign-up to get the 50% discount on this and future events.

Need a Printable Form? Download a registration form you can fax or mail.

Cure for the Common Webinar

In addition to the main faculty presentation, this event includes a fun whiteboard drawing format opening video, a brief moderated faculty interview, and concluding live audience questions and answers. The day before the event, you'll receive login information, including downloadable companion presentation slides.

Just after the event, you'll receive a follow-up request for feedback, also offering an opportunity to provide any final questions that can be forwarded to the faculty. Also, if you need support before, during or after the event, you can contact HealthcareWebSummit staff at any time.

Learning Objectives

After attending this webinar, attendees will be able to:

Understand the implications of applicable telehealth modalities to deploy
Identify and examine key legal and regulatory telehealth issues
Explore corporate formation and corporate practice of medicine considerations
Ascertain potential regulatory developments in the current environment
Engage in interactive learning through online question submission, attendee feedback and opportunity for post-event follow up questions.

Who Should Attend

Interested attendees would include:

C-Suite Executives
Legal and Regulatory Executives and Staff
Telehealth Project Teams
Medical Directors
Medical Affairs Executives and Staff
Clinical Services Executives
Information Technology Executives
Business Development Executives
Planning and Strategic Executives and Staff
Business Intelligence Staff
Other Interested Parties

Attendees would represent organizations including:

Hospitals and Health Systems
Medical Groups
Accountable Care Organizations
Provider Networks
Health Plans
Solutions Providers
Life Sciences Organizations
Consulting Organizations
Associations, Institutes and Research Organizations
Media
Other Interested Organizations

Faculty

Amy Lerman

Amy Lerman
Member of the Firm
Epstein Becker Green

Amy Lerman is a Member of the Firm in the Health Care and Life Sciences practice, in the Washington, DC, office of Epstein Becker Green. Ms. Lerman focuses her practice on a variety of regulatory and transactional health care matters, including telehealth and telemedicine, government investigations, corporate compliance, durable medical equipment, and Medicare program integrity auditing and monitoring. She represents a variety of health care providers and organizations, as well as investors and other financial institutions that invest in or support the health care industry.

In 2018 and 2019, Ms. Lerman was recommended by The Legal 500 United States in the Healthcare: Service Providers category, and she was cited among the "Next Generation Lawyers."

Ms. Lerman:

Counsels telehealth and telemedicine companies, and other health care providers and organizations engaging or seeking to engage in telehealth and telemedicine, regarding various legal and regulatory considerations (see Telehealth & Telemedicine Experience, below)
Counsels telehealth and telemedicine companies, and other health care providers and organizations engaging or seeking to engage in telehealth and telemedicine, regarding various legal and regulatory considerations (see Telehealth & Telemedicine Experience, below)
Advises clients in connection with government investigations relating to health care fraud and abuse
Counsels clients in the areas of federal and state fraud issues, including anti-kickback, self-referral, false claims, and false billings
Advises clients on legal, regulatory, and reimbursement matters arising under the Medicare, Medicaid, and other third-party reimbursement programs
Advises and assists clients in evaluating, developing, and implementing health care corporate compliance programs, and provides ongoing compliance advice and counsel
Advises health providers and health-related companies, financial institutions, and investors of industry trends and policy developments
Represents clients in a variety of health care transactions, including mergers and acquisitions, joint ventures, and affiliations
Conducts health regulatory due diligence reviews
Telehealth & Telemedicine Experience

Ms. Lerman has significant experience advising clients on regulatory considerations related to telehealth, telemedicine, and other mobile health and health technology issues. Her experience includes:

Advising clients on regulatory compliance, reimbursement, coverage, and policy issues related to the use of telehealth, telemedicine, mobile health, and related health technology platforms
Counseling clients on compliance with state and federal laws affecting provision of telehealth and telemedicine services, including issues related to practice of medicine/scope of practice, licensure, online prescribing, reimbursement and coverage, privacy and security, and risk management
Assisting clients with regard to the regulatory issues in establishing regional and national telemedicine networks
In addition, Ms. Lerman co-authored the firm’s Telemental Health Laws app, a comprehensive survey of state telehealth laws, regulations, and policies for mental and behavioral health practitioners and stakeholders across all 50 states and the District of Columbia.

Ms. Lerman is also a co-author of a Bloomberg BNA portfolio publication titled Navigating the Telehealth Landscape: Legal and Regulatory Issues. In 2018 and 2019, Ms. Lerman guest lectured on digital health law at Cornell Tech.

Before joining Epstein Becker Green, Ms. Lerman worked for a technology company providing customized health care provider information, where she assisted with product development and design and supported employer clients using the software. Previously, she worked for a large consulting firm in its health care practice; in this position, she evaluated the design and financing of health and welfare benefit plans for Fortune 500 employer clients.

While attending the University of Maryland School of Law, Ms. Lerman served as the Editor-in-Chief of their Journal of Health Care Law & Policy; worked as a legal intern for the Centers for Medicare & Medicaid Services, where she provided legal research support and drafted legal memoranda regarding agency rulemaking, program review, and allegations brought under the False Claims Act; and served as a legal intern for the State of Maryland Office of the Attorney General, where she assisted prosecutors with preparation for disciplinary proceedings against state health practitioners. Ms. Lerman completed the University of Maryland School of Law concentration in Health Law.

Priya Kaulich

Priya Kaulich
Associate
Epstein Becker Green

Priya Kaulich is an Associate in the Health Care and Life Sciences practice, in the Chicago office of Epstein Becker Green.

Ms. Kaulich:

Counsels telehealth and telemedicine companies regarding various legal and regulatory considerations including corporate practice of medicine, scope of practice, and state licensure requirements
Drafts and negotiates physician employment agreements and management services agreements
Advises pharmaceutical and medical device manufacturers, health care technology companies, and life sciences companies on FDA compliance matters, with a focus on current good manufacturing practices (“CGMPs”), advertising and promotion, and post-market surveillance and reporting
Reviews product labeling and evaluates criteria for substantiation and structure/function, health, disease, and nutrition claims
Advises hospitals and other health care providers on federal and state health care fraud and abuse issues, including anti-kickback and physician self-referral claims
Conducts health regulatory due diligence reviews for mergers and acquisitions in the health care and life sciences industry

Ms. Kaulich is also a member of the Combination Products Coalition, a task force consisting of members of the drug, biologic, and medical device industry, whose aim is to work collaboratively with FDA on regulatory issues affecting combination products. Within the Coalition, she serves as Epstein Becker Green’s representative for the Postmarket Safety Reporting and Bridging Working Groups.

While attending Chicago-Kent College of Law, Ms. Kaulich served as a Notes & Comments Editor of the Chicago-Kent Law Review. She also served as a Legal Intern for a large multinational medical device manufacturer, where she focused on health care regulatory, compliance, and transactional matters.

View full details